A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
Conditions
Atopic Dermatitis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
AllerVie Clinical Research, Birmingham, Alabama, United States
Contact: Principal Investigator (Weily Soong)Dermatology Trial Associates, Bryant, Arkansas, United States
Contact: Principal Investigator (Dowling Stough)Dermatology Research Associates, Los Angeles, California, United States
Contact: Principal Investigator (Howard Sofen)Integrative Skin Science and Research, Sacramento, California, United States
Contact: Principal Investigator (Raja Sivamani)Allergy and Asthma Medical Group and Research Center, San Diego, California, United States
Contact: Principal Investigator (Bob Geng)Clinical Trials Research Institute, Thousand Oaks, California, United States
Contact: Principal Investigator (Navid Ezra)Clarity Dermatology, Castle Rock, Colorado, United States
Contact: Principal Investigator (James Daniel Jensen)Skin Care Research, LLC., Boca Raton, Florida, United States
Contact: Principal Investigator (Ann Mazor Reed)APEX Clinical Trials, Jacksonville, Florida, United States
Contact: Principal Investigator (Pearl Kwong)TruDerm Research, Wellington, Florida, United States
Contact: Principal Investigator (Andleeb Usmani)Cleaver Medical Group Dermatology, Inc, Cumming, Georgia, United States
Contact: Principal Investigator (Weston Waxweiler)Ada West Research, Meridian, Idaho, United States
Contact: Principal Investigator (Elizabeth Swanson)Endeavor Health Clinical Trials Center, Skokie, Illinois, United States
Contact: Principal Investigator (Joel Joyce)Dawes Fretzin Clinical Research Group, LLC, Indianapolis, Indiana, United States
Contact: Principal Investigator (Kenneth Dawes)The Indiana Clinical Trials Center, PC, Plainfield, Indiana, United States
Contact: Principal Investigator (Scott Guenthner)Equity Medical, LLC, Bowling Green, Kentucky, United States
Contact: Principal Investigator (James Allred)Lawrence J Green, MD LLC, Rockville, Maryland, United States
Contact: Principal Investigator (Lawrence Green)Oakland Hills Dermatology, Auburn Hills, Michigan, United States
Contact: Principal Investigator (Christofer Buatti)Minnesota Clinical Study Center, New Brighton, Minnesota, United States
Contact: Principal Investigator (Steven Kempers)SKY Integrative Medical Center, Ridgeland, Mississippi, United States
Contact: Principal Investigator (Jasmine Hollinger)MediSearch Clinical Trials, Saint Joseph, Missouri, United States
Contact: Principal Investigator (Melody Stone)Skin Cancer and Dermatology Institute, Reno, Nevada, United States
Contact: Principal Investigator (Michael Heaphy)Forest Hills Dermatology Group, Kew Gardens, New York, United States
Contact: Principal Investigator (Jeffrey Weinberg)Bobby Buka MD, PC, New York, New York, United States
Contact: Principal Investigator (Andrew Peranteau)Equity Medical, LLC, The Bronx, New York, United States
Contact: Principal Investigator (Alissa McInerney)The University of North Carolina Dermatology and Skin Cancer Center, Chapel Hill, North Carolina, United States
Contact: Principal Investigator (Donna Culton)Dermatologists of Central States, LLC, Fairborn, Ohio, United States
Contact: Principal Investigator (Craig Rohan)Allergy Asthma and Clinical Research Center, Oklahoma City, Oklahoma, United States
Contact: Principal Investigator (Martha Tarpay)Oregon Dermatology and Research Center, Portland, Oregon, United States
Contact: Principal Investigator (Phoebe Rich)Oregon Health & Science University, Portland, Oregon, United States
Contact: Principal Investigator (Tracy Funk)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Principal Investigator (Lara Wine Lee)National Allergy and Asthma Research, LLC., North Charleston, South Carolina, United States
Contact: Principal Investigator (John Ramey)The University of Texas Health Science Center at Houston, Bellaire, Texas, United States
Contact: Principal Investigator (Adelaide Hebert)Dermatology Treatment and Research Center, Dallas, Texas, United States
Contact: Principal Investigator (Ross Radusky)Stryde Research - Epiphany Dermatology, Southlake, Texas, United States
Contact: Principal Investigator (Ronald Todd Plott)Dermatology Specialists of Spokane, Spokane, Washington, United States
Contact: Principal Investigator (Katherine Reed)Dermatology Research Institute, Calgary, Alberta, Canada
Contact: Principal Investigator (Vimal Prajapati)CARe Clinic (Central Alberta Research Clinic), Red Deer, Alberta, Canada
Contact: Principal Investigator (Isaiah Day)Dr. Chih-Ho Hong Medical Inc., Surrey, British Columbia, Canada
Contact: Principal Investigator (Chih-Ho Hong)Manitoba Allergy Research Inc., Winnipeg, Manitoba, Canada
Contact: Principal Investigator (Nestor Cisneros)Maritime Dermatology, Halifax, Nova Scotia, Canada
Contact: Principal Investigator (Natalie Cunningham)Halton Pediatric Allergy, Burlington, Ontario, Canada
Contact: Principal Investigator (Mariam Hanna)Triple A Lab Inc., Hamilton, Ontario, Canada
Contact: Principal Investigator (Jason Ohayon)Allergy Research Canada Inc., Niagara Falls, Ontario, Canada
Contact: Principal Investigator (Vipul Jain)Dr. Rachel Asiniwasis Medical Professional Corporation, Regina, Saskatchewan, Canada
Contact: Principal Investigator (Rachel Asiniwasis)Skinsense Medical Research, Saskatoon, Saskatchewan, Canada
Contact: Principal Investigator (Kirsten Walker)
Study leads
Clinical Lead Late-Stage Clinical Development
Study Director
Organon and Co